Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.55 CHF | -0.32% | -1.81% | +16.33% |
May. 22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
May. 22 | Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.33% | 15.25B | |
+18.71% | 42.33B | |
+21.25% | 22.47B | |
+19.74% | 14.29B | |
+52.83% | 12.6B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.27% | 5.47B | |
+6.91% | 4.78B |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Sandoz Group Logs Growth in Q1 Net Sales, Affirms FY24 Outlook